Fig 4.

Time until definite deterioration analysis for EORTC QLQ‐C30 global health status/QoL and pain scales. Time until definite deterioration for patients who achieved an ≥MR versus non‐responders (i.e. patients with SD, not evaluable, or PD) for the EORTC QLQ‐C30 (A) global health status scale and (B) pain scale. Black, patients who achieved a ≥MR; grey, non‐responders (patients with SD, not evaluable, or PD). CI, confidence interval; EORTC QLQ‐C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire‐Core 30; MR, minimal response; NE, not evaluable; PD, progressive disease; SD, stable disease.